Must Read: DraftKings May Be The Next GW Pharmaceuticals

Seeking Alpha's Must Reads DraftKings May Be The Next GW Pharmaceuticals DraftKings (DKNG) is a leader in the fast-growing US sports betting and iGaming industry. Sports bettors are often "sticky" in terms of the platform they use. DKNG has the most preferred and practical Bitcoin: Get Ready For Another Wave Higher What seems like eons ago now, was essentially only around 2 years ago. Yes, I am talking about a time when Jamie Dimon didn't "care so much" for Bitcoin (BTC-USD), when Warren Buffet was "explainin... Qualcomm: What's Left For Investors After Apple's Moves It was foreseeable that Apple (AAPL) would develop its own 5G chips in the medium term and thus massively reduce its dependence on Qualcomm (QCOM). Apple is massively accelerating its in-house prod... Palantir: Record-Breaking Quarter, ARK Is Still Buying, Mr. Wonderful Picks PLTR Palantir (PLTR) has been my most extensive conviction growth stock since its direct listing around six months ago. It has been a rocky road as PLTR's stock has been highly volatile, exceeding $40 p... Where Will Facebook Stock Be In 10 Years: Likely A Lot Higher Facebook (FB) has built an absolutely dominant position in its market and continues to deliver strong growth. Ad controversies, the introduction of new social networks, and the like can't seem to hurt Download Seeking Alpha for your Phone or Tablet Do you like the content of the Must Reads? How can we improve? Just reply to this email. Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017 By default, clicking links in Seeking Alpha emails auto-logs you into the site. Be careful not to forward this email to anyone you don't want having access to your account. You can change your email security settings here (keep in mind that disabling email auto-login will likely require you to log into your account more frequently). Why are you receiving this? You subscribed to Must Reads at Seeking Alpha. Don't like this email? Unsubscribe here.

Share this

Share on FacebookPlus on Google+